SCHEMBL28983500

SCHEMBL28983500

CC(C)(C)OC(=O)N1CCC(Oc2cc(C(=O)O)c(N)cc2C(F)(F)F)CC1

nearest known ligand 0.46

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
▸ GPR119 Q8TDV5 7/20 0.46
▸ KDM1A O60341 1/20 0.46
▸ PDE4D Q08499 3/20 0.45
▸ PDE4B Q07343 3/20 0.45
▸ PDE4A P27815 2/20 0.45
▸ PDE4C Q08493 2/20 0.45
▸ TOP2A P11388 1/20 0.42
▸ EPHX2 P34913 1/20 0.41
▸ NEK2 P51955 2/20 0.41
▸ STS P08842 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28983485 0.88 GPR119 (0.50) GPR119KDM1APDE4DPDE4BPDE4A
SCHEMBL28983512 0.87 KDM1A (0.48) GPR119KDM1APDE4DPDE4BPDE4A
SCHEMBL1446669 0.86 KDM1A (0.48) GPR119KDM1APDE4DPDE4BPDE4A
SCHEMBL28983519 0.84 GPR119 (0.46) GPR119KDM1APDE4DPDE4BPDE4A
SCHEMBL29686143 0.84 GPR119 (0.46) GPR119KDM1APDE4DPDE4BPDE4A
SCHEMBL14453649 0.83 GPR119 (0.49) GPR119KDM1APDE4DPDE4BPDE4A
SCHEMBL15363254 0.83 KDM1A (0.48) GPR119KDM1APDE4DPDE4BPDE4A
SCHEMBL5864829 0.82 GPR119 (0.53) GPR119KDM1APDE4DPDE4BPDE4A
SCHEMBL8088637 0.80 GPR119 (0.57) GPR119EPHX2NEK2
SCHEMBL29964426 0.80 GPR119 (0.53) GPR119KDM1APDE4DPDE4BPDE4A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115803326-B EGFR inhibitor, preparation method thereof and application thereof in pharmacy 上海和誉生物医药科技有限公司 2024-03-26 — — CN disclosed
CN-115803326-A EGFR inhibitor, preparation method and pharmaceutical application thereof 上海和誉生物医药科技有限公司 2023-03-14 — — CN disclosed
WO-2022105908-A1 EGFR INHIBITOR, PREPARATION METHOD THEREFOR, AND PHARMACEUTICAL APPLICATION THEREOF 上海和誉生物医药科技有限公司 2022-05-27 — — WO disclosed
Send feedback